OPTS Share Price

Open 338.00 Change Price %
High 338.50 1 Day -0.13 -0.04
Low 338.00 1 Week 0.62 0.18
Close 339.62 1 Month 0.62 0.18
Volume 122088 1 Year 0.62 0.18
52 Week High 2.50
52 Week Low 1.40
OPTS Important Levels
Resistance 2 340.08
Resistance 1 339.89
Pivot 338.71
Support 1 339.35
Support 2 339.16
LON UK Most Active Stocks
CWC 74.60 0.27%
CWC 74.60 0.27%
CWC 74.60 0.27%
INC 0.04 -20.00%
GGP 1.70 -2.86%
GGP 1.70 -2.86%
GGP 1.70 -2.86%
FRR 0.60 7.14%
LLOY 68.74 0.66%
HER 0.04 -20.00%
LON UK Top Gainers Stocks
AKT 28.50 5177.78%
HHR 58.00 900.00%
MLD 10.00 700.00%
HAWK 0.50 100.00%
BAF 72.80 86.67%
BAF 72.80 86.67%
BAF 72.80 86.67%
MES 0.28 75.00%
MES 0.28 75.00%
MES 0.28 75.00%
LON UK Top Losers Stocks
ENDV 0.02 -99.85%
KEA 0.10 -91.30%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
DCP 0.50 -75.61%
PCI 3.50 -53.27%
PCI 3.50 -53.27%
BHR 0.02 -33.33%
NBR 0.25 -24.24%


OPTS Technical Analysis 2.5
As on 29th Apr 2015 OPTS Share Price closed @ 339.62 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 247.37 & Strong Sell for SHORT-TERM with Stoploss of 342.25 we also expect STOCK to react on Following IMPORTANT LEVELS.
OPTS Target for June
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
OPTS Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.optos.com
OPTS Address
Queensferry House
Carnegie Campus
Dunfermline, KY11 8GR
United Kingdom
Phone: 44 13 8384 3300
OPTS Latest News
Interactive Technical Analysis Chart Optos PLC ( OPTS LON UK )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Optos PLC
OPTS Business Profile
Optos plc, a retinal imaging company, provides diagnostic and treatment devices to healthcare professionals in North America and internationally. Its medical devices produce ultra-widefield, high resolution digital images of approximately 82% of the retina, which provide clinical information by facilitating the early detection, management, and treatment of disorders and diseases evidenced in the retina, such as retinal detachments and tears, glaucoma, diabetic retinopathy, and age-related macular degeneration. The company’s retinal devices are also used for the treatment of non-eye diseases, including hypertension and cancers. Its ultra-widefield imaging devices include the P200 and 200Dx devices, and the Daytona, which are concentrated on wellness screening carried out in primary care; the P200C devices that are designed to serve the need for clinical imaging capabilities and standards in secondary care within the ophthalmology market and at optometric practices; and the P200MA and 200Tx devices, which support the medical care market. The company also offers optical coherence tomography (OCT) imaging products, such as Optos OCT SLO system, which combines spectral OCT imaging with a confocal scanning ophthalmoscope in an instrument that allows eye care professionals to diagnose and track changes in the retinal diseases and their treatments; Microperimetry that assesses the visual function of a specific area of the retina and fovea, and correlates to the OCT structural changes; and AC Cornea Lens, which provides high-resolution spectral OCT imaging of the cornea and angle. In addition, it provides OCT diagnostic devices and optical ultrasound scanners that are used in the diagnosis and management of eye disease and conditions, as well as develops image management software. The company was founded in 1992 and is headquartered in Dunfermline, the United Kingdom.